Arete Wealth Advisors’s Direxion HCM Tactical Enhanced US ETF HCMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.02M Sell
119,649
-12,931
-10% -$503K 0.33% 77
2026
Q1
$4.67M Sell
132,580
-12,140
-8% -$459K 0.35% 73
2025
Q4
$5.58M Buy
144,720
+9,806
+7% +$378K 0.39% 67
2025
Q3
$5.06M Buy
134,914
+54,015
+67% +$1.87M 0.32% 69
2025
Q2
$2.64M Buy
80,899
+12,992
+19% +$371K 0.19% 112
2025
Q1
$2.05M Buy
67,907
+14,807
+28% +$525K 0.16% 139
2024
Q4
$1.93M Buy
53,100
+34,928
+192% +$1.29M 0.14% 153
2024
Q3
$633K Buy
18,172
+4,049
+29% +$135K 0.05% 314
2024
Q2
$483K Buy
+14,123
New +$437K 0.04% 400

Other funds holding HCMT

Arete Wealth Advisors's HCMT Position: Q2 2026 in Review

Arete Wealth Advisors reduced its Direxion HCM Tactical Enhanced US ETF (HCMT) stake by 9.8% in Q2 2026, selling an estimated $503K and leaving 119,649 shares worth $5.02M. The position accounts for 0.33% of the portfolio, ranked #77.

Arete Wealth Advisors first reported a position in HCMT in Q2 2024 and has held it in 9 quarters since. The position peaked at $5.58M in Q4 2025. 41 funds tracked by Wall St. Rank hold HCMT as of Q2 2026.

  • Arete Wealth Advisors held 119,649 shares of Direxion HCM Tactical Enhanced US ETF worth $5.02M as of Q2 2026.
  • Arete Wealth Advisors sold 12,931 Direxion HCM Tactical Enhanced US ETF shares in Q2 2026, an estimated $503K.
  • Direxion HCM Tactical Enhanced US ETF made up 0.33% of Arete Wealth Advisors's portfolio in Q2 2026, its #77 holding.
  • Arete Wealth Advisors first reported a position in Direxion HCM Tactical Enhanced US ETF in Q2 2024 and has held it in 9 quarters since.
  • Arete Wealth Advisors's Direxion HCM Tactical Enhanced US ETF position peaked at $5.58M in Q4 2025.
  • 41 funds tracked by Wall St. Rank held Direxion HCM Tactical Enhanced US ETF as of Q2 2026.

Based on Arete Wealth Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.